Skip to content

Long‐lasting neuroprotective effect of sildenafil against 3,4‐methylenedioxymethamphetamine‐ induced 5‐hydroxytryptamine deficits in the rat brain

Elena Puerta, Lucía Barros-Miñones, Isabel Hervias, Violeta Gomez‐Rodriguez, Lourdes Orejana, Neus Pizarro, Rafael de la Torre, Joaquı́n Jordán, Norberto Aguirre

Journal of Neuroscience Research September 21, 2011 DOI: 10.1002/jnr.22759 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Controlled animal experiment Peer reviewed
Population Rats
Interventions Sildenafil MDMA
Dose Sildenafil 8 mg/kg p.o.; MDMA 3 × 5 mg/kg i.p.
Duration MDMA injections every 2 hr; measurements one week later
Measures 5-HT content, 5-HT transporter density, ERK1/2 activation, MnSOD expression, ethidium fluorescence, nitrotyrosine concentration
Topics MDMA
Citations 17
Key findings Sildenafil given 24 hours before MDMA significantly protected against MDMA-induced 5-HT depletion in rat striatum, frontal cortex, and hippocampus without altering MDMA's acute hyperthermia or metabolic disposition. The authors attribute this protection to increased ERK1/2 activation and MnSOD expression, with reduced oxidative stress markers (superoxide-derived oxidants and hippocampal nitrotyrosine).

Abstract

Sildenafil, given shortly before 3,4-methylenedioxymethamphetamine (MDMA), affords protection against 5-hydroxytryptamine (5-HT) depletions caused by this amphetamine derivative by an acute preconditioning-like mechanism. Because acute and delayed preconditionings do not share the same mechanisms, we investigated whether sildenafil would also protect the 5-HT system of the rat if given 24 hr before MDMA. For this, MDMA (3 × 5 mg/kg i.p., every 2 hr) was administered to rats previously treated with sildenafil (8 mg/kg p.o.). One week later, 5-HT content and 5-HT transporter density were measured in the striatum, frontal cortex, and hippocampus of the rats. Our findings indicate that sildenafil afforded significant protection against MDMA-induced 5-HT deficits without altering the acute hyperthermic response to MDMA or its metabolic disposition. Sildenafil promoted ERK1/2 activation an effect that was paralleled by an increase in MnSOD expression that persisted 24 hr later. In addition, superoxide and superoxide-derived oxidants, shown by ethidium fluorescence, increased after the last MDMA injection, an effect that was prevented by sildenafil pretreatment. Similarly, MDMA increased nitrotyrosine concentration in the hippocampus, an effect not shown by sildenafil-pretreated rats. In conclusion, our data demonstrate that sildenafil produces a significant, long-lasting neuroprotective effect against MDMA-induced 5-HT deficits. This effect is apparently mediated by an increased expression of MnSOD and a subsequent reduced susceptibility to the oxidative stress caused by MDMA.

Comparable studies

Other preclinical and animal studies on MDMA, most cited first.

Citations in the library

Explore topics